Published in Science on August 23, 2012
Orientation of myosin binding protein C in the cardiac muscle sarcomere determined by domain-specific immuno-EM. J Mol Biol (2014) 1.43
Phosphorylation of cardiac Myosin-binding protein-C is a critical mediator of diastolic function. Circ Heart Fail (2015) 1.29
Myosin-binding protein C corrects an intrinsic inhomogeneity in cardiac excitation-contraction coupling. Sci Adv (2015) 1.21
The contribution of cardiac myosin binding protein-c Ser282 phosphorylation to the rate of force generation and in vivo cardiac contractility. J Physiol (2014) 1.20
Myosin-binding protein C displaces tropomyosin to activate cardiac thin filaments and governs their speed by an independent mechanism. Proc Natl Acad Sci U S A (2014) 1.10
Cardiac MyBP-C regulates the rate and force of contraction in mammalian myocardium. Circ Res (2015) 1.08
GSK3β phosphorylates newly identified site in the proline-alanine-rich region of cardiac myosin-binding protein C and alters cross-bridge cycling kinetics in human: short communication. Circ Res (2012) 1.07
Kinetic characterization of nonmuscle myosin IIb at the single molecule level. J Biol Chem (2012) 1.02
Sarcomere-length dependence of myosin filament structure in skeletal muscle fibres of the frog. J Physiol (2013) 1.01
Age-related slowing of myosin actin cross-bridge kinetics is sex specific and predicts decrements in whole skeletal muscle performance in humans. J Appl Physiol (1985) (2013) 0.98
An endogenously produced fragment of cardiac myosin-binding protein C is pathogenic and can lead to heart failure. Circ Res (2013) 0.96
Post-translational control of cardiac hemodynamics through myosin binding protein C. Pflugers Arch (2013) 0.95
Cardiac myosin binding protein-C as a central target of cardiac sarcomere signaling: a special mini review series. Pflugers Arch (2013) 0.93
The genetic landscape of cardiomyopathy and its role in heart failure. Cell Metab (2015) 0.92
Functional dissection of myosin binding protein C phosphorylation. J Mol Cell Cardiol (2013) 0.91
A gain-of-function mutation in the M-domain of cardiac myosin-binding protein-C increases binding to actin. J Biol Chem (2013) 0.91
Myocardial infarction-induced N-terminal fragment of cardiac myosin-binding protein C (cMyBP-C) impairs myofilament function in human myocardium. J Biol Chem (2014) 0.90
Length-dependent changes in contractile dynamics are blunted due to cardiac myosin binding protein-C ablation. Front Physiol (2014) 0.90
Cardiac myosin binding protein-C: a novel sarcomeric target for gene therapy. Pflugers Arch (2013) 0.90
Increase in cardiac myosin binding protein-C plasma levels is a sensitive and cardiac-specific biomarker of myocardial infarction. Am J Cardiovasc Dis (2013) 0.90
Phosphorylation modulates the mechanical stability of the cardiac myosin-binding protein C motif. Biophys J (2013) 0.88
Phosphorylation of cMyBP-C affects contractile mechanisms in a site-specific manner. Biophys J (2014) 0.87
Cell biology. Heart brakes. Science (2012) 0.87
Titin strain contributes to the Frank-Starling law of the heart by structural rearrangements of both thin- and thick-filament proteins. Proc Natl Acad Sci U S A (2016) 0.84
Cardiac myosin-binding protein-C is a critical mediator of diastolic function. Pflugers Arch (2014) 0.84
Phosphorylation and calcium antagonistically tune myosin-binding protein C's structure and function. Proc Natl Acad Sci U S A (2016) 0.84
Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-C. J Mol Cell Cardiol (2015) 0.84
Surviving the infarct: A profile of cardiac myosin binding protein-C pathogenicity, diagnostic utility, and proteomics in the ischemic myocardium. Proteomics Clin Appl (2014) 0.82
Cardiac Myosin-binding Protein C and Troponin-I Phosphorylation Independently Modulate Myofilament Length-dependent Activation. J Biol Chem (2015) 0.82
Structure, sarcomeric organization, and thin filament binding of cardiac myosin-binding protein-C. Pflugers Arch (2014) 0.82
Effects of a myofilament calcium sensitizer on left ventricular systolic and diastolic function in rats with volume overload heart failure. Am J Physiol Heart Circ Physiol (2014) 0.81
Cardiac myosin-binding protein C: hypertrophic cardiomyopathy mutations and structure-function relationships. Pflugers Arch (2013) 0.81
Cardiac myosin binding protein C regulates postnatal myocyte cytokinesis. Proc Natl Acad Sci U S A (2015) 0.80
Molecule specific effects of PKA-mediated phosphorylation on rat isolated heart and cardiac myofibrillar function. Arch Biochem Biophys (2016) 0.80
Normal cardiac contraction in mice lacking the proline-alanine rich region and C1 domain of cardiac myosin binding protein C. J Mol Cell Cardiol (2015) 0.79
Kinetic Adaptations of Myosins for Their Diverse Cellular Functions. Traffic (2016) 0.79
Omecamtiv Mecarbil Enhances the Duty Ratio of Human Beta Cardiac Myosin Resulting in Increased Calcium Sensitivity and Slowed Force Development in Cardiac Muscle. J Biol Chem (2017) 0.79
ADP-stimulated contraction: A predictor of thin-filament activation in cardiac disease. Proc Natl Acad Sci U S A (2015) 0.78
Kinetics of cardiac myosin isoforms in mouse myocardium are affected differently by presence of myosin binding protein-C. J Muscle Res Cell Motil (2014) 0.78
Molecular modulation of actomyosin function by cardiac myosin-binding protein C. Pflugers Arch (2014) 0.78
Loss of myocardial retinoic acid receptor α induces diastolic dysfunction by promoting intracellular oxidative stress and calcium mishandling in adult mice. J Mol Cell Cardiol (2016) 0.77
Myofilament dysfunction as an emerging mechanism of volume overload heart failure. Pflugers Arch (2014) 0.77
Molecular modeling of disease causing mutations in domain C1 of cMyBP-C. PLoS One (2013) 0.77
Use of fluorescent techniques to study the in vitro movement of myosins. EXS (2014) 0.76
The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position. J Mol Cell Cardiol (2015) 0.76
Slowing of contractile kinetics by myosin-binding protein C can be explained by its cooperative binding to the thin filament. J Mol Cell Cardiol (2015) 0.75
In the spotlight: Cardiovascular engineering. IEEE Rev Biomed Eng (2012) 0.75
HEART DISEASE. Throttling back the heart's molecular motor. Science (2016) 0.75
Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy. PLoS One (2017) 0.75
Modifications of myofilament protein phosphorylation and function in response to cardiac arrest induced in a swine model. Front Physiol (2015) 0.75
Phosphoregulation of Tau modulates inhibition of kinesin-1 motility. Mol Biol Cell (2017) 0.75
A post-MI power struggle: adaptations in cardiac power occur at the sarcomere level alongside MyBP-C and RLC phosphorylation. Am J Physiol Heart Circ Physiol (2016) 0.75
Cardiac myosin binding protein-C Ser(302) phosphorylation regulates cardiac β-adrenergic reserve. Sci Adv (2017) 0.75
Alterations in Multi-Scale Cardiac Architecture in Association With Phosphorylation of Myosin Binding Protein-C. J Am Heart Assoc (2016) 0.75
Taking a translational turn. J Gen Physiol (2012) 0.75
Disassembly of myofibrils and potential imbalanced forces on Z-discs in cultured adult cardiomyocytes. Cytoskeleton (Hoboken) (2016) 0.75
Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics (2005) 6.37
Mechanochemical coupling in actomyosin energy transduction studied by in vitro movement assay. J Mol Biol (1990) 4.78
Automatic tracking of individual fluorescence particles: application to the study of chromosome dynamics. IEEE Trans Image Process (2005) 3.64
Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction? EMBO J (1995) 3.28
Cardiac myosin-binding protein-C phosphorylation and cardiac function. Circ Res (2005) 2.67
Protein kinase A-mediated acceleration of the stretch activation response in murine skinned myocardium is eliminated by ablation of cMyBP-C. Circ Res (2006) 2.50
Cardiac myosin binding protein C phosphorylation is cardioprotective. Proc Natl Acad Sci U S A (2006) 2.46
Three-dimensional structure of vertebrate cardiac muscle myosin filaments. Proc Natl Acad Sci U S A (2008) 2.39
Acceleration of crossbridge kinetics by protein kinase A phosphorylation of cardiac myosin binding protein C modulates cardiac function. Circ Res (2008) 2.07
Smooth, cardiac and skeletal muscle myosin force and motion generation assessed by cross-bridge mechanical interactions in vitro. J Muscle Res Cell Motil (1994) 1.85
Direct visualization of myosin-binding protein C bridging myosin and actin filaments in intact muscle. Proc Natl Acad Sci U S A (2011) 1.83
Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay. Am J Physiol Heart Circ Physiol (2007) 1.82
Loaded shortening, power output, and rate of force redevelopment are increased with knockout of cardiac myosin binding protein-C. Circ Res (2003) 1.81
Effects of the N-terminal domains of myosin binding protein-C in an in vitro motility assay: Evidence for long-lived cross-bridges. J Biol Chem (2006) 1.81
In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament. Circ Res (2011) 1.81
Polarity and velocity of sliding filaments: control of direction by actin and of speed by myosin. Science (1990) 1.76
Cardiac myosin binding protein C. Circ Res (1999) 1.61
Myosin-binding protein C phosphorylation, myofibril structure, and contractile function during low-flow ischemia. Circulation (2005) 1.59
Understanding the organisation and role of myosin binding protein C in normal striated muscle by comparison with MyBP-C knockout cardiac muscle. J Mol Biol (2008) 1.57
Cardiac myosin binding protein-C phosphorylation in a {beta}-myosin heavy chain background. Circulation (2009) 1.52
C-protein limits shortening velocity of rabbit skeletal muscle fibres at low levels of Ca2+ activation. J Physiol (1991) 1.52
Nonlinear elasticity and an 8-nm working stroke of single myosin molecules in myofilaments. Science (2010) 1.41
Unique single molecule binding of cardiac myosin binding protein-C to actin and phosphorylation-dependent inhibition of actomyosin motility requires 17 amino acids of the motif domain. J Mol Cell Cardiol (2011) 1.40
Electron microscopy and 3D reconstruction of F-actin decorated with cardiac myosin-binding protein C (cMyBP-C). J Mol Biol (2011) 1.37
Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle. J Mol Cell Cardiol (2008) 1.36
Structure and interactions of myosin-binding protein C domain C0: cardiac-specific regulation of myosin at its neck? J Biol Chem (2011) 1.31
Identification of novel protein kinase A phosphorylation sites in the M-domain of human and murine cardiac myosin binding protein-C using mass spectrometry analysis. J Proteome Res (2010) 1.28
Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction. J Mol Cell Cardiol (2011) 1.27
The molecular basis of frictional loads in the in vitro motility assay with applications to the study of the loaded mechanochemistry of molecular motors. Cytoskeleton (Hoboken) (2010) 1.20
Roles for cardiac MyBP-C in maintaining myofilament lattice rigidity and prolonging myosin cross-bridge lifetime. Biophys J (2011) 1.11
Effect of extraction of myosin binding protein C on contractility of rat heart. Am J Physiol Heart Circ Physiol (2003) 1.09
Mechanical unfolding of cardiac myosin binding protein-C by atomic force microscopy. Biophys J (2011) 1.03
Actin sliding on reconstituted myosin filaments containing only one myosin heavy chain isoform. J Muscle Res Cell Motil (2003) 0.91
A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell (1998) 13.56
The Sleep Heart Health Study: design, rationale, and methods. Sleep (1997) 7.55
Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol (1995) 7.28
Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem (1991) 4.45
Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J Biol Chem (1991) 4.34
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer (1998) 3.55
Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group. J Am Geriatr Soc (2000) 3.48
Self-reported causes of physical disability in older people: the Cardiovascular Health Study. CHS Collaborative Research Group. J Am Geriatr Soc (1994) 3.05
The nucleoplasmin nuclear location sequence is larger and more complex than that of SV-40 large T antigen. J Cell Biol (1988) 2.85
Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest (1996) 2.63
Observations of fouling biofilm formation. Can J Microbiol (1981) 2.56
Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. Circ Res (2001) 2.51
Cardiac physiology in transgenic mice. Circ Res (1998) 2.47
Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science (1998) 2.39
Cardiotrophic effects of protein kinase C epsilon: analysis by in vivo modulation of PKCepsilon translocation. Circ Res (2000) 2.38
Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. Circ Res (2000) 2.35
Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res (1991) 2.34
Smooth muscle and skeletal muscle myosins produce similar unitary forces and displacements in the laser trap. Biophys J (1997) 2.28
Incidence of fractures compared to cardiovascular disease and breast cancer: the Women's Health Initiative Observational Study. Osteoporos Int (2008) 2.27
Smooth and skeletal muscle myosin both exhibit low duty cycles at zero load in vitro. J Biol Chem (1993) 2.27
Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study. JAMA (1992) 2.21
Cloning and sequencing of a putative Escherichia coli [NiFe] hydrogenase-1 operon containing six open reading frames. J Bacteriol (1990) 2.20
The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I. Conceptual foundation and item development. Dysphagia (2000) 2.18
Age effects on the temporal evolution of isometric and swallowing pressure. J Gerontol A Biol Sci Med Sci (2000) 2.15
Transgenic remodeling of the contractile apparatus in the mammalian heart. Circ Res (1996) 2.05
Actin filament mechanics in the laser trap. J Muscle Res Cell Motil (1997) 1.97
Myosin V exhibits a high duty cycle and large unitary displacement. J Cell Biol (2001) 1.95
Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Invest (1999) 1.95
Smooth, cardiac and skeletal muscle myosin force and motion generation assessed by cross-bridge mechanical interactions in vitro. J Muscle Res Cell Motil (1994) 1.85
Mouse model of desmin-related cardiomyopathy. Circulation (2001) 1.84
Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab (1995) 1.84
Increased myocardial Rab GTPase expression: a consequence and cause of cardiomyopathy. Circ Res (2001) 1.83
Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay. Am J Physiol Heart Circ Physiol (2007) 1.82
High body fatness, but not low fat-free mass, predicts disability in older men and women: the Cardiovascular Health Study. Am J Clin Nutr (1998) 1.82
A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Invest (1998) 1.77
Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol (1994) 1.74
Apolipoprotein J: structure and tissue distribution. Biochemistry (1990) 1.73
The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: II. Item reduction and preliminary scaling. Dysphagia (2000) 1.72
Mutational analysis and characterization of the Escherichia coli hya operon, which encodes [NiFe] hydrogenase 1. J Bacteriol (1991) 1.71
Immunological studies of Y protein. A major cytoplasmic organic anion-binding protein in rat liver. J Clin Invest (1972) 1.71
Comparison of effortful and noneffortful swallows in healthy middle-aged and older adults. Arch Phys Med Rehabil (2001) 1.68
Rescue of cardiac alpha-actin-deficient mice by enteric smooth muscle gamma-actin. Proc Natl Acad Sci U S A (1997) 1.68
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67
Computer-assisted tracking of actin filament motility. Anal Biochem (1992) 1.65
A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. J Clin Invest (1998) 1.65
Structure-function relationships among the nickel-containing hydrogenases. FEMS Microbiol Rev (1992) 1.62
Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments. Circ Res (1993) 1.61
A 7-amino-acid insert in the heavy chain nucleotide binding loop alters the kinetics of smooth muscle myosin in the laser trap. J Muscle Res Cell Motil (1998) 1.61
Predicting hospital choice for rural Medicare beneficiaries: the role of severity of illness. Health Serv Res (1991) 1.61
Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. Am J Physiol Heart Circ Physiol (2000) 1.60
Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2. J Biol Chem (1999) 1.60
Phenotypic deficits in mice expressing a myosin binding protein C lacking the titin and myosin binding domains. J Mol Cell Cardiol (2001) 1.59
Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. J Biol Chem (1991) 1.56
Cloned genomic DNA sequences from Mycoplasma hyorhinis encoding antigens expressed in Escherichia coli. Proc Natl Acad Sci U S A (1983) 1.54
DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors. Cancer Res (1998) 1.53
The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J Biol Chem (2001) 1.53
Two heads of myosin are better than one for generating force and motion. Proc Natl Acad Sci U S A (1999) 1.53
The essential light chain is required for full force production by skeletal muscle myosin. Proc Natl Acad Sci U S A (1994) 1.52
Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. Circ Res (1995) 1.52
Factors associated with healthy aging: the cardiovascular health study. J Am Geriatr Soc (2001) 1.51
In vivo analysis of the murine beta-myosin heavy chain gene promoter. J Biol Chem (1993) 1.50
Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. Circ Res (2000) 1.49
Forskolin inhibits and reverses the effects of brefeldin A on Golgi morphology by a cAMP-independent mechanism. J Cell Biol (1991) 1.48
In vitro chamber specification during embryonic stem cell cardiogenesis. Expression of the ventricular myosin light chain-2 gene is independent of heart tube formation. J Biol Chem (1993) 1.45
R403Q and L908V mutant beta-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level. J Muscle Res Cell Motil (2000) 1.44
The isolation and partial characterization of recombinant DNA containing genomic globin sequences from the goat. J Biol Chem (1979) 1.44
Kinetic differences at the single molecule level account for the functional diversity of rabbit cardiac myosin isoforms. J Physiol (1999) 1.43
A treadmill exercise regimen for identifying cardiovascular phenotypes in transgenic mice. Am J Physiol (1997) 1.42
Depression in primary care: patient factors that influence recognition. Fam Med (1997) 1.39
Transgenic remodeling of the regulatory myosin light chains in the mammalian heart. Circ Res (1997) 1.39
Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. J Biol Chem (1990) 1.38
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid (1998) 1.33
The sequence of an embryonic myosin heavy chain gene and isolation of its corresponding cDNA. J Biol Chem (1987) 1.31
Test-retest variability in normal swallowing. Dysphagia (1990) 1.30
Thermal application reduces the duration of stage transition in dysphagia after stroke. Dysphagia (1996) 1.30
Transgenic analysis of the thyroid-responsive elements in the alpha-cardiac myosin heavy chain gene promoter. J Biol Chem (1993) 1.29
Characterization of a macrolide, lincosamide, and streptogramin resistance plasmid in Staphylococcus epidermidis. J Bacteriol (1981) 1.28
The active tension-length curve of vascular smooth muscle related to its cellular components. J Gen Physiol (1979) 1.28
Cross-bridge elasticity in single smooth muscle cells. J Gen Physiol (1983) 1.28
Measurement of intraventricular pressure and cardiac performance in the intact closed-chest anesthetized mouse. Am J Physiol (1997) 1.27
Enhanced force generation by smooth muscle myosin in vitro. Proc Natl Acad Sci U S A (1994) 1.27
Receptor-mediated uptake of 3,3',5-triiodo-L-thyronine by cultured fibroblasts. Proc Natl Acad Sci U S A (1980) 1.25
The impact of age and gender on papillary thyroid cancer survival. J Clin Endocrinol Metab (2012) 1.25
Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. Am J Physiol (1994) 1.24
Exercise treatment for sacroiliac pain. Orthopedics (2001) 1.23
Molecular basis of thyroid hormone regulation of myelin basic protein gene expression in rodent brain. J Biol Chem (1991) 1.23
A preliminary report on the effect of measured strength training in adolescent idiopathic scoliosis. J Spinal Disord (2000) 1.23
Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice. J Clin Invest (1997) 1.23
Relation of smoking with carotid artery wall thickness and stenosis in older adults. The Cardiovascular Health Study. The Cardiovascular Health Study (CHS) Collaborative Research Group. Circulation (1994) 1.22
Carboxy-terminal processing of the large subunit of [NiFe] hydrogenases. FEBS Lett (1993) 1.21